Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Mustang Bio Inc (MBIO)

Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Next-Gen Cancer Treatments Gain Steam Amid Oncology Industry Shakeups BayStreet.ca - Thu Jul 10, 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer rates are climbing across the U.S., with stark disparities from state to state. Recent CDC data...

ONCY : 0.8050 (-4.17%)
INAB : 1.3700 (-2.84%)
ONC.TO : 1.42 (+2.16%)
TNGX : 19.21 (-0.26%)
MBIO : 0.7251 (+0.29%)
ELVN : 36.59 (-5.77%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies FinancialNewsMedia - Tue Jul 8, 2025

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MBIO),(NASDAQ:VSTM),(NASDAQ:CRDF),(NASDAQ:AZN) EQNX::TICKER_END

ONCY : 0.8050 (-4.17%)
AZN : 193.88 (+2.90%)
ONC.TO : 1.42 (+2.16%)
VSTM : 4.85 (-3.77%)
CRDF : 1.5500 (unch)
MBIO : 0.7251 (+0.29%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies GlobeNewswire - Tue Jul 8, 2025

ONCY : 0.8050 (-4.17%)
AZN : 193.88 (+2.90%)
ONC.TO : 1.42 (+2.16%)
VSTM : 4.85 (-3.77%)
CRDF : 1.5500 (unch)
MBIO : 0.7251 (+0.29%)
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma GlobeNewswire - Mon Jul 7, 2025

FBIO : 2.70 (-2.17%)
MBIO : 0.7251 (+0.29%)
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement GlobeNewswire - Wed Mar 5, 2025

FBIO : 2.70 (-2.17%)
MBIO : 0.7251 (+0.29%)
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility GlobeNewswire - Thu Feb 27, 2025

MBIO : 0.7251 (+0.29%)
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire - Tue Feb 11, 2025

MBIO : 0.7251 (+0.29%)
Mustang Bio Announces Closing of $8 Million Public Offering GlobeNewswire - Mon Feb 10, 2025

MBIO : 0.7251 (+0.29%)
Mustang Bio Announces Pricing of $8 Million Public Offering GlobeNewswire - Thu Feb 6, 2025

MBIO : 0.7251 (+0.29%)
Mustang Bio Announces Reverse Stock Split GlobeNewswire - Tue Jan 14, 2025

MBIO : 0.7251 (+0.29%)

Barchart Exclusives

Meta Platforms Just Made Entergy a Top Stock to Buy... and It Pays a 2.49% Dividend Barchart - Mon Mar 30, 6:30PM CDT
Meta’s decision to fully fund seven new natural gas plants, 240 miles of 500 kV transmission, batteries, and up to 2.5 GW of solar to power its giant Louisiana AI data center effectively gives Entergy a multi‑decade growth runway with limited bill pressure on other customers, which is a rare setup for a regulated utility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.